ClinicalTrials.gg
Not yet recruitingNCT07935512PAPE_OTTUpdated Nov 13, 2026

Clinical and Instrumental Assessment and Evaluation of Return to Sport in Patients Who Underwent Surgical Treatment for Posterolateral Corner (PLC) Injuries Associated With Anterior Cruciate Ligament (ACL) Injuries.

An observational study in Anterior Cruciate Ligament (ACL) and Posterolateral Corner, sponsored by Stefano Zaffagnini. Not yet recruiting at 1 site in Italy. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Stefano Zaffagnini · Observational

How we know

Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
16
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This is a single-centre, observational retrospective and prospective study aimed at evaluating the clinical and functional outcomes of patients who underwent combined anterior cruciate ligament (ACL) and posterolateral corner (PLC) reconstruction using the Over-The-Top (OTT) technique.

The primary outcome is the improvement in knee function, assessed using the Lysholm Knee Score by comparing pre-injury/preoperative status with postoperative follow-up. Secondary outcomes include knee stability, assessed through clinical examinations and instrumental measurements (KT-1000, KiRA, PIVOT App and Telos stress radiographs), return to sport, pain, MRI findings and postoperative complications.

Patients aged 18-65 years with a minimum follow-up of 24 months will be included. The study aims to provide evidence on the effectiveness of the combined ACL and PLC reconstruction using the OTT technique.

02

Conditions studied

  • Anterior Cruciate Ligament (ACL)
  • Posterolateral Corner
03

In context

Lead sponsor

Stefano Zaffagnini is the lead sponsor of 16 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients will be recruited from both male and female individuals aged between 18 and 65 years (inclusive) at the time of surgery, presenting with combined anterior cruciate ligament (ACL) and posterolateral corner (PLC) injuries of the knee, who underwent surgical treatment at the II Orthopaedic and Traumatologic Clinic of the Rizzoli Orthopaedic Institute. Surgical treatment consisted of ACL reconstruction using the Over-The-Top (OTT) technique combined with posterolateral corner reconstruction, performed between January 1, 2017, and December 31, 2025.

Only patients with a minimum follow-up of 24 months from the date of surgery will be enrolled.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male and female patients;
  • Patients aged between 18 and 65 years at the time of surgery;
  • Patients who underwent anterior cruciate ligament (ACL) reconstruction using the Over-The-Top (OTT) technique combined with posterolateral corner (PLC) reconstruction;
  • Patients who underwent surgery between January 1, 2017, and December 31, 2025;
  • Patients who underwent preoperative imaging examinations (MRI and, if applicable, X-rays) of the affected knee confirming the diagnosis of ACL and posterolateral corner injuries;
  • Patients who underwent isolated ACL + PLC reconstruction or ACL + PLC reconstruction combined with additional procedures on the same knee (e.g., meniscal treatment or concomitant ligament injuries);
  • Patients who provided written to participate in the study.

Exclusion criteria

Exclusion Criteria

  • History of fractures of the same limb requiring surgical treatment;
  • History of posterolateral corner (PLC) injuries of the knee requiring surgical treatment;
  • Patients younger than 18 years or older than 65 years at the time of surgery;
  • Patients who did not provide ;
  • Patients who are no longer contactable.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
16 participants (estimated)
Patient registry
No

Interventions

  • ProcedurePosterolateral corner

    Patients with combined anterior cruciate ligament (ACL) and posterolateral corner (PLC) injuries of the knee, surgically treated with ACL reconstruction using the Over-The-Top (OTT) technique combined with posterolateral corner reconstruction.

06

What researchers measure

Primary outcomes

  1. Lysholm Knee Score

    The Lysholm Knee Score is a validated assessment tool used to evaluate knee function through 8 items addressing the knee's ability to meet the functional demands of daily activities. It is commonly used to assess surgical outcomes in patients undergoing treatment for knee ligament or meniscal injuries. The total score is calculated by summing the scores of the individual items, ranging from 0 to 100. Scores are classified as follows: Excellent (95-100), Good (84-94), Fair (65-83), and Poor (\<64).

    Time frame: Minimum 24 months

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Sep 2028, 21 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 13, 2026
StartEst.
Dec 2026
Primary completionEst.
Sep 2028
CompletionEst.
Sep 2028
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07935512
Lead sponsor
Stefano Zaffagnini
Responsible party
Stefano Zaffagnini (Full Professor Medicine and Surgery, University of Bologna, Istituto Ortopedico Rizzoli) — Sponsor-investigator
First posted
Nov 13, 2026
Start date
Dec 2026 (estimated)
Primary completion
Sep 2028 (estimated)
Completion
Sep 2028 (estimated)
Last update
Nov 13, 2026

Study contacts

Stefano Zaffagnini
Contact
stefano.zaffagnini@ior.it
0516366075

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion